regenerative therapy irb Tag

R3 Stem Cell announced today that the company has achieved IRB Approval for its regenerative study titled, “Safety and Clinical Outcomes Study: Amniotic and Umbilical Cord Tissue Administration for Orthopedic, Neurologic, Urologic, Autoimmune, Cardiac, Renal and Pulmonary Conditions”. The company will be acquiring data for...

Contact Informations


Contact us

Join Our Email List